DIVI'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,672 INR | -1.00% |
|
-2.86% | -5.95% |
| Apr. 19 | Indian Equities Close Higher on Friday, Led by Metal, Banking Stocks | MT |
| Apr. 12 | Indian Equities Close Lower on Friday As Hopes for US Rate Cute in June Fade | MT |
ETFs positioned on Divi's Laboratories Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.68% | 6 M€ | +6.07% | - | |
| 0.20% | 11 M€ | -0.93% | ||
| 0.09% | 18 M€ | +1.50% | ||
| 0.08% | 2,808 M€ | +2.67% | - | |
| 0.08% | 441 M€ | +1.71% | - | |
| 0.08% | 149 M€ | -1.09% | - | |
| 0.07% | 4 M€ | -4.41% | - | |
| 0.06% | 117 M€ | -1.55% | - | |
| 0.03% | 31 M€ | +1.30% | - | |
| 0.03% | 7 M€ | -0.18% | - | |
| 0.02% | 7 M€ | +19.95% | - | |
| 0.01% | 15 M€ | +5.11% | ||
| 0.01% | 34 M€ | +1.25% | - | |
| 0.01% | 34 M€ | +5.42% | - | |
| 0.01% | 389 M€ | +5.07% | - | |
| 0.01% | 16 M€ | -9.75% | ||
| 0.00% | 147 M€ | +4.13% | - | |
| 0.00% | 39 M€ | +3.09% | - | |
| 0.00% | 302 M€ | +3.37% | - |
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.
Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%).
At the end of March 2020, the group has 2 production sites located in India.
Sector
Pharmaceuticals
Calendar
2024-05-26
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
25
Last Close Price
3,672
INR
Average target price
3,444
INR
Spread / Average Target
-6.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.95% | 11.78B | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
- Stock Market
- Equities
- DIVISLAB Stock
- Funds and ETFs Divi's Laboratories Limited
